| Dr Kari D Fitzsimmons, MD | |
|
3927 Rucker Ave, Everett, WA 98201-4833 | |
| (425) 339-5422 | |
| Not Available |
| Full Name | Dr Kari D Fitzsimmons |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 21 Years |
| Location | 3927 Rucker Ave, Everett, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124053871 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00046328 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Everett Clinic Pllc | 6406752153 | 552 |
News Archive
Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.
The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in Science.
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
A new study from the scientists at the University of Houston reveals specific neuromarkers for Parkinson's disease. Deep brain stimulation for Parkinson's disease could now be targeted towards cells carrying these markers in the brain and thus become more accurate and specific explain the researchers.
› Verified 6 days ago
| Entity Name | The Polyclinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174594634 PECOS PAC ID: 2163328196 Enrollment ID: O20031210000788 |
News Archive
Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.
The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in Science.
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
A new study from the scientists at the University of Houston reveals specific neuromarkers for Parkinson's disease. Deep brain stimulation for Parkinson's disease could now be targeted towards cells carrying these markers in the brain and thus become more accurate and specific explain the researchers.
› Verified 6 days ago
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.
The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in Science.
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
A new study from the scientists at the University of Houston reveals specific neuromarkers for Parkinson's disease. Deep brain stimulation for Parkinson's disease could now be targeted towards cells carrying these markers in the brain and thus become more accurate and specific explain the researchers.
› Verified 6 days ago
| Entity Name | Seattle Emergency Physicians Services Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376642298 PECOS PAC ID: 4284521691 Enrollment ID: O20040301001149 |
News Archive
Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.
The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in Science.
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
A new study from the scientists at the University of Houston reveals specific neuromarkers for Parkinson's disease. Deep brain stimulation for Parkinson's disease could now be targeted towards cells carrying these markers in the brain and thus become more accurate and specific explain the researchers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kari D Fitzsimmons, MD Po Box 5127, Everett, WA 98206-5127 Ph: () - | Dr Kari D Fitzsimmons, MD 3927 Rucker Ave, Everett, WA 98201-4833 Ph: (425) 339-5422 |
News Archive
Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.
The deadly attack of the bacterium that causes pneumonic plague is significantly slowed when it can't make use of a key protein, scientists at Washington University School of Medicine in St. Louis report in Science.
Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) has provided an additional grant to fund clinical studies for the Company's Addiction program. This grant, which is for a total of approximately $3.6 million to be paid over a four-year period in equal amounts, will fund direct and indirect costs of Phase 2 clinical studies to be conducted by researchers at the New York State Psychiatric Institute.
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
A new study from the scientists at the University of Houston reveals specific neuromarkers for Parkinson's disease. Deep brain stimulation for Parkinson's disease could now be targeted towards cells carrying these markers in the brain and thus become more accurate and specific explain the researchers.
› Verified 6 days ago
Dr. Kurt R. Duffens, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3927 Rucker Ave, Everett, WA 98201 Phone: 425-339-5422 Fax: 425-339-5444 | |
Arunachalam Einstein, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-261-2000 | |
Daniel A Zak, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-261-2000 | |
James Goldberg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1716 W Marine View Dr Ste C, Everett, WA 98201 Phone: 425-259-0212 | |
Dr. Joseph Primo Mazzoncini Jr., M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1700 13th St, Everett, WA 98201 Phone: 425-261-2000 | |
Eric Cooper, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-261-2000 | |
Cynthia A Markus, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1321 Colby Ave, Everett, WA 98201 Phone: 425-261-2000 |